Market Valuation & Earnings Multiples
Market capitalization, P/E ratios, and enterprise value
Market Cap5.98B
Enterprise Value5.58B
Trailing P/E8.89
PTCT
(NASDAQ)PTC Therapeutics, Inc.
$67.77-- (--)
Loading... - Market loading
PTC Therapeutics (PTCT) Key Statistics & Financial Metrics
Complete stock analysis with 40+ metrics: valuation ratios, profitability margins, financial health indicators, and dividend data.
Stock Valuation Metrics
Market value, earnings multiples, and pricing ratios
Price-Based Ratios
Valuation ratios based on stock price
Price/Sales (ttm)3.51
Forward Price/Sales1.64
Price/FCF (ttm)13.61
Price/OCF (ttm)8.54
Enterprise Value Ratios
EV-based valuation multiples
EV/Revenue3.22
EV/Earnings8.17
EV/EBITDA6.29
EV/EBIT6.35
EV/FCF12.51
Stock Price
Current price, 52-week range, and moving averages
Current Price$67.77
1-Day Change0.91%
52-Week High$87.50
52-Week Low$35.95
52-Week Change47.53%
YTD Change-10.41%
1-Year Change42.13%
50-Day MA$69.50
200-Day MA$64.36
Avg Volume (30 day)482.97K
Share Statistics
Outstanding shares, float, and per-share metrics
Shares Outstanding88.31M
Book Value per Share$-2.32
Net Cash per Share$7.73
FCF per Share$5.05
Analyst Price Targets & Consensus
Wall Street analyst ratings and 12-month price targets (90 days)
Price Target$91.33
Target Upside/Downside34.76%
Analyst ConsensusBuy
Analyst Count6
Profitability & Financial Performance
Profit margins, return metrics, and earnings analysis
Profit Margins
Profitability margins across income statement
Gross Margin96.74%
EBITDA Margin (ttm)51.29%
EBIT Margin (ttm)50.80%
Operating Margin (ttm)49.49%
Pretax Margin (ttm)40.25%
Profit Margin (ttm)39.44%
FCF Margin (ttm)25.78%
Return on Investment Metrics
ROE, ROA, ROIC, and capital efficiency ratios
Return on Assets (ttm)23.45%
Return on Capital Employed (ttm)45.25%
Income Statement (TTM)
Trailing twelve months revenue and earnings
Revenue1.73B
Gross Profit1.67B
Operating Income856.51M
Pretax Income696.62M
Net Income682.64M
EBITDA887.66M
EBIT879.11M
Diluted EPS$8.46
Cash Flow (TTM)
Operating cash flow and free cash flow metrics
Operating Cash Flow711.20M
Capital Expenditures265.10M
Free Cash Flow446.10M
Growth Rates (YoY)
Year-over-year growth metrics
Revenue Growth114.51%
Financial Health & Dividends
Balance sheet analysis, debt ratios, and dividend metrics
Assets & Cash
Total assets and cash positions
Total Assets (mrq)2.91B
Cash & Securities (mrq)984.65M
Net Cash (mrq)682.53M
Net Cash per Share$7.73
Debt & Liabilities
Liabilities, debt, equity, and working capital
Total Debt (mrq)492.28M
Working Capital (mrq)1.31B
Total Equity (mrq)-205.31M
Book Value per Share$-2.32
Liquidity & Leverage
Liquidity, leverage, and debt coverage ratios
Current Ratio (mrq)2.35
Quick Ratio (mrq)2.27
Debt/EBITDA (ttm)0.55
Debt/FCF (ttm)1.10
Dividend History & Payout Analysis
Dividend yield, payout ratios, and growth metrics
Dividend per Share (TTM)$0.00
Dividend Yield0.00%
Payout Ratio (Earnings)0.00%
Yield Metrics
Earnings, FCF, buyback, and shareholder yields
Earnings Yield11.24%
FCF Yield7.35%
Buyback Yield0.00%
Total Shareholder Yield0.00%
Financial Health Scores
Risk assessment and quality metrics
Altman Z-Score1.87
Piotroski F-Score7/9
Frequently Asked Questions About PTC Therapeutics Statistics
What are the key financial metrics for PTCT?
PTC Therapeutics, Inc. (PTCT) statistics include 40+ financial metrics organized into valuation ratios (P/E, P/S, P/B, PEG), profitability margins (gross, operating, net), return metrics (ROE, ROA, ROIC), and financial health indicators. These are updated regularly based on the latest filings and market data.
What is PTCT's valuation analysis?
The valuation section covers market capitalization, earnings multiples like trailing and forward P/E, price-based ratios (P/S, P/B, Price/FCF), and enterprise value ratios (EV/EBITDA, EV/Revenue, EV/FCF). Compare these against sector averages to assess whether PTC Therapeutics is overvalued or undervalued.
How do I read PTCT's profitability ratios?
PTC Therapeutics's profitability is measured through profit margins (gross, EBITDA, operating, net) and return metrics (ROE, ROA, ROIC, ROCE). Higher margins indicate better cost control, while higher returns show efficient capital deployment. The income statement and cash flow sections provide the underlying revenue and earnings data.
What do PTCT's debt ratios indicate?
The financial health section shows PTC Therapeutics's leverage through debt-to-equity, debt-to-assets, debt-to-EBITDA, and debt-to-FCF ratios, plus liquidity via the current and quick ratios. Lower debt ratios and higher liquidity ratios generally indicate stronger financial stability and lower default risk.
What is PTCT's dividend analysis?
The dividend section covers PTC Therapeutics's dividend yield, payout ratios (earnings-based and FCF-based), year-over-year dividend growth, years of consecutive growth, ex-dividend and pay dates, and payment frequency. The yield metrics section also includes earnings yield, FCF yield, buyback yield, and total shareholder yield.